For Which COVID-19 Patients Has Been Approved Remdesivir?

For which COVID-19 patients has been approved Remdesivir? On October 22, 2020, the FDA approved the antiviral drug Veklury (remdesivir) for use in adults and pediatric patients (12 years of age and older and weighing at least 40 kg) for the treatment of COVID-19 requiring hospitalization.

Who might benefit from dexamethasone if they have COVID-19?


Related guide for For Which COVID-19 Patients Has Been Approved Remdesivir?


Was this post helpful?

Leave a Reply

Your email address will not be published.